These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38777564)

  • 21. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial.
    Iyengar K; Paul M; Iyengar SD; Klingberg-Allvin M; Essén B; Bring J; Soni S; Gemzell-Danielsson K
    Lancet Glob Health; 2015 Sep; 3(9):e537-45. PubMed ID: 26275330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.
    Purcell C; Cameron S; Lawton J; Glasier A; Harden J
    BJOG; 2017 Dec; 124(13):2001-2008. PubMed ID: 28421651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
    Goldstone P; Walker C; Hawtin K
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):366-371. PubMed ID: 28303569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2017-19 governmental decisions to allow home use of misoprostol for early medical abortion in the UK.
    Parsons JA
    Health Policy; 2020 Jul; 124(7):679-683. PubMed ID: 32487442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expulsion at home for early medical abortion: A systematic review with meta-analyses.
    Schmidt-Hansen M; Pandey A; Lohr PA; Nevill M; Taylor P; Hasler E; Cameron S
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):727-735. PubMed ID: 33063314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.
    Chong E; Frye LJ; Castle J; Dean G; Kuehl L; Winikoff B
    Contraception; 2015 Sep; 92(3):215-9. PubMed ID: 26142620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving access to medicines for early medical abortion: learning from experiences of medicines licensing and service delivery.
    Rowlands S; Harrison-Woolrych M
    BMJ Sex Reprod Health; 2023 Oct; 49(4):234-237. PubMed ID: 37640520
    [No Abstract]   [Full Text] [Related]  

  • 31. Induction of abortion in early first trimester human pregnancy using epostane.
    Webster MA; Gillmer MD
    Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study supports the introduction of early medical abortion in Turkey.
    Akin A; Kocoglu GO; Akin L
    Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective open-label study of home use of mifepristone for medical abortion in Nepal.
    Conkling K; Karki C; Tuladhar H; Bracken H; Winikoff B
    Int J Gynaecol Obstet; 2015 Mar; 128(3):220-3. PubMed ID: 25482435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of acceptability of RU486 and ONO 802 in a Chinese population.
    Tang GW
    Contraception; 1991 Nov; 44(5):523-32. PubMed ID: 1797467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. At-home telemedicine for medical abortion in Australia: a qualitative study of patient experiences and recommendations.
    Fix L; Seymour JW; Sandhu MV; Melville C; Mazza D; Thompson TA
    BMJ Sex Reprod Health; 2020 Jul; 46(3):172-176. PubMed ID: 32665231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review.
    Ngo TD; Park MH; Shakur H; Free C
    Bull World Health Organ; 2011 May; 89(5):360-70. PubMed ID: 21556304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Home use of misoprostol for early medical abortion in a low resource setting: secondary analysis of a randomized controlled trial.
    Iyengar K; Klingberg-Allvin M; Iyengar SD; Paul M; Essén B; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2016 Feb; 95(2):173-81. PubMed ID: 26565074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy.
    Podolskyi V; Gemzell-Danielsson K; Maltzman LL; Marions L
    Acta Obstet Gynecol Scand; 2023 May; 102(5):541-548. PubMed ID: 36933004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.
    Paul M; Iyengar K; Iyengar S; Gemzell-Danielsson K; Essén B; Klingberg-Allvin M
    BMC Womens Health; 2014 Aug; 14():98. PubMed ID: 25127545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical methods of early abortion in developing countries. Consensus statement. The Population Council.
    Contraception; 1998 Nov; 58(5):257-9. PubMed ID: 9883380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.